Physician profile
William L Bennett
NPI 1023288792
$5,995.87
in general payments reported to CMS, 2019-2025
18 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $379 · 2020: $258 · 2021: $1,898 · 2022: $1,755 · 2023: $1,258 · 2024: $287 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,066 · Travel and Lodging: $640.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,066.17 |
| Travel and Lodging | $639.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,342.85 | 2022-2023 | Venaseal |
| Janssen Pharmaceuticals, INC | $1,815.96 | 2019-2023 | Xarelto |
| Penumbra, INC. | $343.12 | 2023-2024 | Indigo System |
| Janssen Scientific Affairs, LLC | $305.74 | 2020-2023 | Xarelto |
| Abbott Laboratories | $250.49 | 2019-2021 | |
| Bard Peripheral Vascular, INC. | $248.31 | 2020-2021 | |
| Amgen INC. | $210.86 | 2024-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $103.48 | 2019 | |
| Chiesi USA, INC. | $94.74 | 2021 | |
| Novartis Pharmaceuticals Corporation | $65.92 | 2021-2023 | |
| Kestra Medical Technology Services, INC. | $48.78 | 2024 | Assure Wcd |
| Baxter Healthcare | $44.12 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Boston Scientific Corporation | $34.86 | 2020 | |
| Abiomed | $24.17 | 2022 | |
| Cardiva Medical, INC. | $21.46 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $17.06 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.